Form4insider filings, from the source

SEC Form 4 · accession 0001609351-18-000010

Spark Therapeutics, Inc. · ONCE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Joseph La Barge
Officer — Chief Legal Officer
Period of report
Jan 18, 2018
Accepted (ET)
Jan 22, 2018 · 7:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 18, 2018M1,750—A7,075D
Common StockJan 18, 2018F635$50.55D6,440D
Common Stockholding———200IHeld by Reporting Person's immediate family members

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F2$50.55Jan 18, 2018A28,000A—Jan 17, 2028Common Stock28,00028,000D
Restricted Stock UnitsF3,F4—Jan 18, 2018A8,000A——Common Stock8,0008,000D
Restricted Stock UnitsF3,F5—Jan 18, 2018M1,750D——Common Stock1,7505,250D

Explanation of responses